Damian J. Green MD

Damian Green, M.D., is a board-certified hematology oncologist at SCCA, an assistant member at Fred Hutchinson Cancer Research Center, and a UW assistant professor of Medical Oncology. Dr. Green specializes in bone marrow transplantation for blood disorders. He aims to work closely with patients to design individualized treatment plans that may incorporate a broad range of options, including innovative therapies. Dr. Green earned his M.D. at Ohio State. His clinical interests include multiple myeloma, lymphoma, amyloidosis, bone marrow transplantation, and radioimmunotherapy.

Dr. Damian Green develops new immunotherapies that harness the power of the immune system to treat and ultimately eradicate multiple myeloma and lymphoma. A major research focus is radioimmunotherapy, in which radioactive particles are linked to cancer-targeting molecules called antibodies to deliver deadly radiation straight to cancer cells while sparing healthy tissues. Dr. Green also studies a type of immunotherapy called bispecific antibody therapy in which a two-pronged antibody brings together cancer-killing immune cells and cancer cells. Another major focus of his work is the development and clinical evaluation of a form of genetically engineered T-cell therapy (called CAR T-cell therapy) for patients with myeloma.